This is an old revision of the document!
Acylcarnitines
Acute myopathy, rhabdomyolysis. Unexplained increased creatine kinase
Notes
- serum acylcarnitines are useful in the diagnosis of fatty acid oxidation disorders and several organic acidurias
- also useful in evaluating treatment during follow-up of patients with fatty acid beta-oxidation disorders and several organic acidurias
- specific acylcarnitines indicate particular disorders, e.g. octanoyl carnitine in MCAD deficiency, glutaryl carnitine in GA1, propionyl carnitine in cobalamin disorders
< or =7 days (nmol/mL) | < or =7 days (nmol/mL) |
8 days-7 years | 8 days-7 years |
(nmol/mL) | (nmol/mL) |
> or =8 years | > or =8 years |
(nmol/mL) | (nmol/mL) |
Acetylcarnitine, C2 | Acetylcarnitine, C2 |
2.14-15.89 | 2.14-15.89 |
2.00-27.57 | 2.00-27.57 |
2.00-17.83 | 2.00-17.83 |
Acrylylcarnitine, C3:1 | Acrylylcarnitine, C3:1 |
<0.04 | <0.04 |
<0.05 | <0.05 |
<0.07 | <0.07 |
Propionylcarnitine, C3 | Propionylcarnitine, C3 |
<0.55 | <0.55 |
<1.78 | <1.78 |
<0.88 | <0.88 |
Formiminoglutamate, FIGLU | Formiminoglutamate, FIGLU |
<0.43 | <0.43 |
<0.08 | <0.08 |
<0.14 | <0.14 |
Iso-/Butyrylcarnitine, C4 | Iso-/Butyrylcarnitine, C4 |
<0.46 | <0.46 |
<1.06 | <1.06 |
<0.83 | <0.83 |
Tiglylcarnitine, C5:1 | Tiglylcarnitine, C5:1 |
<0.05 | <0.05 |
<0.09 | <0.09 |
<0.11 | <0.11 |
Isovaleryl-/2-Methylbutyrylcarn C5 | Isovaleryl-/2-Methylbutyrylcarn C5 |
<0.38 | <0.38 |
<0.63 | <0.63 |
<0.51 | <0.51 |
3-OH-iso-/butyrylcarnitine, C4-OH | 3-OH-iso-/butyrylcarnitine, C4-OH |
<0.13 | <0.13 |
<0.51 | <0.51 |
<0.18 | <0.18 |
Hexenoylcarnitine, C6:1 | Hexenoylcarnitine, C6:1 |
<0.12 | <0.12 |
<0.10 | <0.10 |
<0.15 | <0.15 |
Hexanoylcarnitine, C6 | Hexanoylcarnitine, C6 |
<0.14 | <0.14 |
<0.23 | <0.23 |
<0.17 | <0.17 |
3-OH-isovalerylcarnitine, C5-OH | 3-OH-isovalerylcarnitine, C5-OH |
<0.08 | <0.08 |
<0.12 | <0.12 |
<0.10 | <0.10 |
Benzoylcarnitine | Benzoylcarnitine |
<0.13 | <0.13 |
<0.07 | <0.07 |
<0.10 | <0.10 |
Heptanoylcarnitine, C7 | Heptanoylcarnitine, C7 |
<0.05 | <0.05 |
<0.05 | <0.05 |
<0.06 | <0.06 |
3-OH-hexanoylcarnitine, C6-OH | 3-OH-hexanoylcarnitine, C6-OH |
<0.08 | <0.08 |
<0.19 | <0.19 |
<0.09 | <0.09 |
Phenylacetylcarnitine | Phenylacetylcarnitine |
<0.15 | <0.15 |
<0.22 | <0.22 |
<0.29 | <0.29 |
Salicylcarnitine | Salicylcarnitine |
<0.08 | <0.08 |
<0.09 | <0.09 |
<0.09 | <0.09 |
Octenoylcarnitine, C8:1 | Octenoylcarnitine, C8:1 |
<0.48 | <0.48 |
<0.91 | <0.91 |
<0.88 | <0.88 |
Octanoylcarnitine, C8 | Octanoylcarnitine, C8 |
<0.19 | <0.19 |
<0.45 | <0.45 |
<0.78 | <0.78 |
Malonylcarnitine, C3-DC | Malonylcarnitine, C3-DC |
<0.09 | <0.09 |
<0.14 | <0.14 |
<0.26 | <0.26 |
Decadienoylcarnitine, C10:2 | Decadienoylcarnitine, C10:2 |
<0.11 | <0.11 |
<0.12 | <0.12 |
<0.26 | <0.26 |
Decenoylcarnitine, C10:1 | Decenoylcarnitine, C10:1 |
<0.25 | <0.25 |
<0.46 | <0.46 |
<0.47 | <0.47 |
Decanoylcarnitine, C10 | Decanoylcarnitine, C10 |
<0.27 | <0.27 |
<0.91 | <0.91 |
<0.88 | <0.88 |
Methylmalonyl-/succinylcarn, C4-DC | Methylmalonyl-/succinylcarn, C4-DC |
<0.05 | <0.05 |
<0.05 | <0.05 |
<0.05 | <0.05 |
3-OH-decenoylcarnitine, C10:1-OH | 3-OH-decenoylcarnitine, C10:1-OH |
<0.12 | <0.12 |
<0.12 | <0.12 |
<0.13 | <0.13 |
Glutarylcarnitine, C5-DC | Glutarylcarnitine, C5-DC |
<0.06 | <0.06 |
<0.10 | <0.10 |
<0.11 | <0.11 |
Dodecenoylcarnitine, C12:1 | Dodecenoylcarnitine, C12:1 |
<0.19 | <0.19 |
<0.37 | <0.37 |
<0.35 | <0.35 |
Dodecanoylcarnitine, C12 | Dodecanoylcarnitine, C12 |
<0.18 | <0.18 |
<0.35 | <0.35 |
<0.26 | <0.26 |
3-Methylglutarylcarnitine, C6-DC | 3-Methylglutarylcarnitine, C6-DC |
<0.28 | <0.28 |
<0.21 | <0.21 |
<0.43 | <0.43 |
3-OH-dodecenoylcarnitine, C12:1-OH | 3-OH-dodecenoylcarnitine, C12:1-OH |
<0.11 | <0.11 |
<0.10 | <0.10 |
<0.13 | <0.13 |
3-OH-dodecanoylcarnitine, C12-OH | 3-OH-dodecanoylcarnitine, C12-OH |
<0.06 | <0.06 |
<0.09 | <0.09 |
<0.08 | <0.08 |
Tetradecadienoylcarnitine, C14:2 | Tetradecadienoylcarnitine, C14:2 |
<0.09 | <0.09 |
<0.13 | <0.13 |
<0.18 | <0.18 |
Tetradecenoylcarnitine, C14:1 | Tetradecenoylcarnitine, C14:1 |
<0.16 | <0.16 |
<0.35 | <0.35 |
<0.24 | <0.24 |
Tetradecanoylcarnitine, C14 | Tetradecanoylcarnitine, C14 |
<0.11 | <0.11 |
<0.15 | <0.15 |
<0.12 | <0.12 |
Octanedioylcarnitine, C8-DC | Octanedioylcarnitine, C8-DC |
<0.25 | <0.25 |
<0.19 | <0.19 |
<0.19 | <0.19 |
3-OH-tetradecenoylcarnitine C14:1OH | 3-OH-tetradecenoylcarnitine C14:1OH |
<0.06 | <0.06 |
<0.18 | <0.18 |
<0.13 | <0.13 |
3-OH-tetradecanoylcarnitine, C14-OH | 3-OH-tetradecanoylcarnitine, C14-OH |
<0.04 | <0.04 |
<0.05 | <0.05 |
<0.08 | <0.08 |
Hexadecenoylcarnitine, C16:1 | Hexadecenoylcarnitine, C16:1 |
<0.15 | <0.15 |
<0.21 | <0.21 |
<0.10 | <0.10 |
Hexadecanoylcarnitine, C16 | Hexadecanoylcarnitine, C16 |
<0.36 | <0.36 |
<0.52 | <0.52 |
<0.23 | <0.23 |
3-OH-hexadecenoylcarnitine,C16:1-OH | 3-OH-hexadecenoylcarnitine,C16:1-OH |
<0.78 | <0.78 |
<0.36 | <0.36 |
<0.06 | <0.06 |
3-OH-hexadecanoylcarnitine, C16-OH | 3-OH-hexadecanoylcarnitine, C16-OH |
<0.10 | <0.10 |
<0.07 | <0.07 |
<0.06 | <0.06 |
Octadecadienoylcarnitine, C18:2 | Octadecadienoylcarnitine, C18:2 |
<0.12 | <0.12 |
<0.31 | <0.31 |
<0.24 | <0.24 |
Octadecenoylcarnitine, C18:1 | Octadecenoylcarnitine, C18:1 |
<0.25 | <0.25 |
<0.45 | <0.45 |
<0.39 | <0.39 |
Octadecanoylcarnitine, C18 | Octadecanoylcarnitine, C18 |
<0.10 | <0.10 |
<0.12 | <0.12 |
<0.14 | <0.14 |
Dodecanedioylcarnitine, C12-DC | Dodecanedioylcarnitine, C12-DC |
<0.10 | <0.10 |
<0.04 | <0.04 |
<0.04 | <0.04 |
3-OH-octadecadienoylcarn, C18:2-OH | 3-OH-octadecadienoylcarn, C18:2-OH |
<0.04 | <0.04 |
<0.06 | <0.06 |
<0.06 | <0.06 |
3-OH-octadecenoylcarnitine C18:1-OH | 3-OH-octadecenoylcarnitine C18:1-OH |
<0.03 | <0.03 |
<0.04 | <0.04 |
<0.06 | <0.06 |
3-OH-octadecanoylcarnitine, C18-OH | 3-OH-octadecanoylcarnitine, C18-OH |
<0.03 | <0.03 |
<0.05 | <0.05 |
<0.03 | <0.03 |
Discussion